AIM ImmunoTech Inc.
AIM- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946644
In the last 90 days, AIM ImmunoTech Inc. insiders filed 4 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $325.6K in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in AIM ImmunoTech Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +5 vs. Q3 2021
- Shares held
- 7.47M
- +164.2K (+2.2%) vs. Q3 2021
- Total value
- $6.86M
- −$7.88M (−53.5%) vs. Q3 2021
- New holders
- 10
- 7 more added
- Sold out
- 5
- 10 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AIM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $325.6K |
| Q1 2026 | 18 | $102.8K |
| Q4 2025 | 13 | $119.8K |
| Q3 2025 | 15 | $293.9K |
| Q2 2025 | 12 | $104.8K |
| Q1 2025 | 34 | $590.0K |
| Q4 2024 | 35 | $919.3K |
| Q3 2024 | 33 | $2.43M |
| Q2 2024 | 36 | $3.15M |
| Q1 2024 | 33 | $1.93M |
| Q4 2023 | 38 | $1.83M |
| Q3 2023 | 38 | $1.97M |
| Q2 2023 | 34 | $3.01M |
| Q1 2023 | 36 | $2.05M |
| Q4 2022 | 39 | $1.67M |
| Q3 2022 | 38 | $3.36M |
| Q2 2022 | 40 | $4.68M |
| Q1 2022 | 38 | $7.12M |
| Q4 2021 | 43 | $6.86M |
| Q3 2021 | 38 | $14.7M |
| Q2 2021 | 39 | $15.5M |
| Q1 2021 | 38 | $16.8M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding AIM ImmunoTech Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 2,041,382 | $1.88M | 0.00% | −342,997−14.4% | Reduced |
| Vanguard Group Inc | 2,000,285 | $1.84M | 0.00% | −2,571−0.1% | Reduced |
| BlackRock Inc. | 834,303 | $767.0K | 0.00% | +6,145+0.7% | Added |
| Renaissance Technologies LLC | 705,100 | $649.0K | 0.00% | +705,100 | New |
| Geode Capital Management, LLC | 372,953 | $343.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 301,297 | $277.0K | 0.00% | −69,346−18.7% | Reduced |
| Bridgeway Capital Management, LLC | 216,000 | $199.0K | 0.00% | −20,000−8.5% | Reduced |
| Verition Fund Management LLC | 162,000 | $149.0K | 0.00% | +13,521+9.1% | Added |
| State Street Corp | 160,413 | $148.0K | 0.00% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 116,800 | $107.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 88,662 | $82.0K | 0.00% | +246+0.3% | Added |
| Raymond James Financial Services Advisors, Inc. | 48,450 | $45.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 41,052 | $37.0K | 0.00% | +41,052 | New |
| Rockefeller Capital Management L.P. | 40,000 | $36.0K | 0.00% | 00.0% | Unchanged |
| SeaCrest Wealth Management, LLC | 38,563 | $35.0K | 0.00% | −5,000−11.5% | Reduced |
| Susquehanna International Group, LLP | 37,812 | $35.0K | 0.00% | +1,663+4.6% | Added |
| Virtu Financial LLC | 37,657 | $35.0K | 0.00% | +37,657 | New |
| Bank of New York Mellon Corp | 27,565 | $25.0K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 24,035 | $22.0K | 0.00% | −17,060−41.5% | Reduced |
| Captrust Financial Advisors | 20,000 | $18.0K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 16,482 | $15.0K | 0.00% | 00.0% | Unchanged |
| Winton Group Ltd | 15,693 | $14.0K | 0.00% | −66,871−81.0% | Reduced |
| Bank of America Corp | 15,089 | $14.0K | 0.00% | −617−3.9% | Reduced |
| Jane Street Group, LLC | 15,499 | $14.0K | 0.00% | +15,499 | New |
| Millennium Management LLC | 12,970 | $12.0K | 0.00% | −41,406−76.1% | Reduced |
| Community Bank, N.A. | 13,226 | $12.0K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 11,100 | $10.0K | 0.00% | −100−0.9% | Reduced |
| Traynor Capital Management, Inc. | 11,777 | $10.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 11,794 | $10.0K | 0.00% | +1,001+9.3% | Added |
| SNS Financial Group, LLC | 10,000 | $9.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,872 | $4.00K | 0.00% | +4,872 | New |
| Advisor Group Holdings, Inc. | 3,455 | $3.00K | 0.00% | +2,000+137.5% | Added |
| Stephens Consulting, LLC | 3,000 | $2.76K | 0.00% | +3,000 | New |
| JPMorgan Chase & Co | 2,620 | $2.00K | 0.00% | +22+0.8% | Added |
| Howe & Rusling Inc | 1,500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Hoey Investments, Inc | 1,000 | $1.00K | 0.00% | +1,000 | New |
| TD Waterhouse Canada Inc. | 170 | $220 | 0.00% | +170 | New |
| American Portfolios Advisors | 228 | $210 | 0.00% | 00.0% | Unchanged |
| Proequities, Inc. | 500 | $0 | 0.00% | 00.0% | Unchanged |
| Huntington National Bank | 57 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 10 | $0 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 100 | $0 | 0.00% | +100 | New |
| Royal Bank of Canada | 1 | $0 | 0.00% | +1 | New |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −46,679−100.0% | Sold out |
| Arkadios Wealth Advisors | 0 | $0 | 0.00% | −21,597−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −18,774−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −15,826−100.0% | Sold out |
| Jacobi Capital Management LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |